Pulmonary Disease, Chronic Obstructive
11 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Air cleaner for pulmonary disease, chronic obstructive | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Benralizumab for pulmonary disease, chronic obstructive | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| clonal fetal MSCs for pulmonary disease, chronic obstructive | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| CM326 dose 1 + CM326 dose 2 for pulmonary disease, chronic obstructive | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Depemokimab for pulmonary disease, chronic obstructive | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Quality-of-Life Assessment + Questionnaire Administration + Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine for pulmonary disease, chronic obstructive | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Semaglutide for pulmonary disease, chronic obstructive | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sildenafil Citrate for pulmonary disease, chronic obstructive | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tozorakimab for pulmonary disease, chronic obstructive | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 6 |
| TQC2731 injection for pulmonary disease, chronic obstructive | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Treprostinil for pulmonary disease, chronic obstructive | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |